Sanjay Bhojraj
Interventional Cardiology · Murrieta, CANPI 1124090303
Payments from drug & device makers
Across 433 payments — averaging $298.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$35K
- Boehringer Ingelheim$25K
- Johnson & Johnson$24K
- AstraZeneca$18K
- Abbott$9K
- Bayer$8K
- plus $11K from 31 others
What the payments were for
- Consulting fees$4,4003%
- Speaking & faculty fees$107,19683%
- Travel & lodging$5,2954%
- Food & beverage$12,43810%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 28 | $34,860 |
| Boehringer Ingelheim | 39 | $24,623 |
| Johnson & Johnson | 37 | $23,559 |
| AstraZeneca | 41 | $18,116 |
| Abbott | 39 | $9,216 |
| Bayer | 11 | $8,116 |
| Edwards Lifesciences | 31 | $4,456 |
| Shockwave Medical, Inc | 6 | $811 |
| Amgen | 35 | $735 |
| Boston Scientific | 17 | $703 |
| Medtronic(2 entities) | 15 | $630 |
| Pfizer | 38 | $561 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $410 |
| Chiesi USA, Inc. | 20 | $338 |
| Novartis | 11 | $322 |
| Biosense Webster, Inc. | 4 | $251 |
| Abiomed | 5 | $194 |
| Biotronik Inc. | 5 | $174 |
| Cleerly, Inc. | 2 | $150 |
| GE HealthCare | 1 | $136 |
| Novo Nordisk | 6 | $135 |
| E.r. Squibb & Sons, L.L.C. | 8 | $133 |
| Cathworks, Inc. | 2 | $112 |
| Cardiovascular Systems Inc. | 6 | $110 |
| Heartflow, Inc. | 1 | $87 |
| Itamar Medical Inc | 1 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Merck | 3 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Cook Medical LLC | 1 | $53 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $23 |
| Aegerion Pharmaceuticals, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$58,838
- XARELTO$23,126
- FARXIGA$17,543
- Kerendia$7,965
- Mitra Clip system$2,860
- ABSOLUTE PRO$2,500
- SUPERA$2,000
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,839
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$466
- PERCLOSE PROGLIDE$398
- Edwards SAPIEN XT Transcatheter Heart Valve$370
- Vascular Lithotripsy$332
- Edwards SAPIEN 3 Transcatheter Heart Valve$271
- WATCHMAN Access System$250
- MitraClip System$248
- CoreValve Evolut$245
- Watchman$235
- COREVALVE EVOLUT R$170
- MitraClip$143
- Xience Sierra Coronary Stent System$137
How this compares
$129,383 in reported general payments places this provider in the 80th percentile of 585 interventional cardiology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 13 | $10,854 |
| Losartan Potassium | 18 | $245 |
| Atorvastatin Calcium | 16 | $203 |
| Metoprolol Tartrate | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Murrieta
- Rajendra MakkarWest Hollywood$16.6M
- Fahed BitarCovina$9.9M
- Rahul SharmaStanford$6.6M
- Matthew Pricela Jolla$5.8M
- David LeeStanford$5.7M
- Saibal KarThousand Oaks$5.4M
- Mehrdad ArianiNorthridge$5M
- Frederick St GoarMountain View$4.2M
- Sammy ElmariahSan Francisco$4.2M
- William FearonStanford$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.